A population based study describing the utilization of biologic medications and immunomodulators among patients with Heart failure and ulcerative colitis
Latest Information Update: 07 Jul 2021
At a glance
- Drugs Adalimumab (Primary) ; Azathioprine (Primary) ; Balsalazide (Primary) ; Golimumab (Primary) ; Infliximab (Primary) ; Mercaptopurine (Primary) ; Mesalazine (Primary) ; Methotrexate (Primary) ; Olsalazine (Primary) ; Sulfasalazine (Primary) ; Tofacitinib (Primary) ; Ustekinumab (Primary) ; Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 07 Jul 2021 New trial record
- 23 May 2021 Results presented at the Digestive Disease Week 2021